The measure adopted by the French authorities on 16 August 2016 regarding the Terrafor and Defiligne medical devices, in order to suspend their placing on the market and provide for the withdrawal of these devices from the market, is justified.
資料由法律人 LawPlayer整理提供·EU law / curated by LawPlayer from EUR-Lex
Decision
Commission Decision (EU) 2018/1617 of 25 October 2018 concerning a measure adopted by France pursuant to Council Directive 93/42/EEC with regard to the Terrafor and Defiligne medical devices (notified under document C(2018) 6943) (Text with EEA relevance.)
Article 1
Article 2
This Decision is addressed to the Member States.
2 articles
Cite this act
Commission Decision (EU) 2018/1617 of 25 October 2018 concerning a measure adopted by France pursuant to Council Directive 93/42/EEC with regard to the Terrafor and Defiligne medical devices (notified under document C(2018) 6943) (Text with EEA relevance.) (EUR-Lex). Retrieved via LawPlayer, https://lawplayer.com/eu/act/32018D1617
© European Union, https://eur-lex.europa.eu, 1998-2026. Reuse authorised under Commission Decision 2011/833/EU, provided the source is acknowledged.
本頁資料來源:EUR-Lex·整理提供:法律人 LawPlayer· lawplayer.com